CorMedix Inc. (CRMD) › Operating Cash FlowCorMedix Inc. (CRMD) — Operating Cash FlowAnnual figures by period end, from SEC filings.2010-12-31: -$3.67M2011-12-31: -$6.30M2012-12-31: -$2.28M2013-12-31: -$3.62M2014-12-31: -$6.32M2015-12-31: -$12.53M2016-12-31: -$22.27M2017-12-31: -$28.59M2018-12-31: -$23.70M2019-12-31: -$15.05M2020-12-31: -$21.97M2021-12-31: -$21.16M2022-12-31: -$24.36M2023-12-31: -$38.41M2024-12-31: -$50.62M2025-12-31: $175.05M$175.05M2010-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$175.05M—2026-03-05From 2025-01-012024-12-31-$50.62M—2026-03-05From 2024-01-012023-12-31-$38.41M—2025-03-25From 2023-01-012022-12-31-$24.36M—2024-03-12From 2022-01-012021-12-31-$21.16M—2023-03-30From 2021-01-012020-12-31-$21.97M—2022-03-29From 2020-01-012019-12-31-$15.05M—2021-03-30From 2019-01-012018-12-31-$23.70M—2020-03-16From 2018-01-012017-12-31-$28.59M—2019-05-29From 2017-01-012016-12-31-$22.27M—2018-03-19From 2016-01-012015-12-31-$12.53M—2017-03-16From 2015-01-012014-12-31-$6.32M—2017-03-16From 2014-01-012013-12-31-$3.62M—2015-03-12From 2013-01-012012-12-31-$2.28M—2014-03-31From 2012-01-012011-12-31-$6.30M—2014-03-04From 2011-01-012010-12-31-$3.67M—2012-04-26From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)